|
RGT-490 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Regor Pharmaceuticals Inc.1
Indications
- PIK3CA Mutation1
- Hormone Receptor Positive Tumor1
- Unresectable Solid Tumor1
- HER2-negative Breast Cancer1
- Advanced Breast Cancer1
Houston, Texas1 trial
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.